Speedy Antigen COVID-19 At-Dwelling Check, 4-Pack Equipment, FDA Emergency Use Approved (EUA), Fast Outcomes, Simple to make use of, nasal take a look at, Distributed by Roche Diagnostics

Worth: $39.99 - $32.80
(as of Jul 29,2022 01:10:35 UTC – Particulars)

From the producer

COVID-19 At-Dwelling Check: Accuracy Issues

95.3% relative sensitivity and 100% relative specificity

The accuracy of the COVID-19 At-Dwelling Check offers you with a outcome you’ll be able to belief and the boldness you’ll want to take management. If you want a COVID-19 take a look at, Accuracy Issues.

COVID-19 At-Dwelling Check is an easy-to-use, correct and dependable speedy antigen take a look at that delivers leads to as few as 20 minutes. It may be self-administered by people ages 14 and up, and adults can administer the take a look at for kids ages 2 to 13.

Roche continues to watch the evolution of SARS-CoV-2 variants and stays dedicated to offering high-quality testing options that help within the analysis of sufferers with SARS-CoV-2. The COVID-19 At-Dwelling Check detects COVID-19, together with the Omicron and Delta variants.

Product Dimensions ‏ : ‎ 6.1 x 5 x 1.1 inches; 2.89 Ounces
Merchandise mannequin quantity ‏ : ‎ 09666672161
Date First Accessible ‏ : ‎ March 4, 2022
Producer ‏ : ‎ SD Biosensor
ASIN ‏ : ‎ B09TWXWXX3
Nation of Origin ‏ : ‎ Korea, Republic of

The COVID-19 At-Dwelling Check Distributed by Roche | Speedy antigen take a look at for the detection of COVID-19 by folks with or with out COVID-19 signs.
EASY TO USE, non-invasive nasal swab for people 14 years or older. Grownup assortment for people aged 2 years to 13 years previous is required.
DETECTS COVID-19, together with omicron and delta variants, amongst others. The efficiency of this take a look at within the detection of the omicron variant of SARS-CoV-2 was evaluated utilizing affected person samples.
FDA EUA COVID-19 At-Dwelling Check Distributed by Roche is a lateral circulate immunoassay supposed for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in 20 minutes.
Supposed Use: This take a look at is allowed for 1) non-prescription dwelling use throughout the first 6 days of symptom onset, 2) non-prescription dwelling use with or with out signs or different epidemiological causes to suspect COVID-19 when examined twice over three days with at the very least 24 hours (and not more than 48 hours) between assessments.